SCHEMBL2811790

SCHEMBL2811790

c1cc(N2CCN(c3nc4c5c(n3)NNC5CCN4)CC2)ccn1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 1/20 0.42
NCF1 P14598 1/20 0.42
PLD1 Q13393 1/20 0.42
CHKA P35790 1/20 0.38
MAPT P10636 3/20 0.33
ROCK1 Q13464 1/20 0.33
LMNA P02545 2/20 0.32
CETP P11597 2/20 0.32
DHFR P00374 1/20 0.32
TSHR P16473 2/20 0.32
ALDH1A1 P00352 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
PIK3CA P42336 1/20 0.31
DRD2 P14416 2/20 0.31
DRD4 P21917 2/20 0.31
DRD3 P35462 2/20 0.31
KDM1A O60341 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2812178 0.83 HTT (0.35) LMNATSHRALDH1A1PIK3CAPOLB
SCHEMBL2808545 0.79 PIK3CA (0.38) MAPTLMNATSHRALDH1A1PIK3CA
SCHEMBL538336 0.73 MAPT (0.37) MAPTLMNATSHRALDH1A1HTT
SCHEMBL28112415 0.66 CHKA (0.80) ADRB2NCF1PLD1CHKAMAPT
SCHEMBL2811779 0.66 ADRB2 (0.41) ADRB2NCF1PLD1CHKAMAPT
SCHEMBL12595271 0.65 HRH4 (0.56) ADRB2NCF1PLD1CHKAMAPT
SCHEMBL74335 0.61 ADRB2 (1.00) ADRB2NCF1PLD1CHKALMNA
SCHEMBL894239 0.61 ADRB2 (1.00) ADRB2NCF1PLD1CHKALMNA
SCHEMBL4761698 0.60 ADRB2 (0.67) ADRB2NCF1PLD1CHKATSHR
Hydrochloric Acid SCHEMBL639824 0.60 ADRB2 (0.96) ADRB2NCF1PLD1CHKALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8343983-B2 Substituted pyrazolo-pyrimidine compounds ARQULE, INC. (US) 2013-01-01 US disclosed
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS ARQULE, INC. (US) 2010-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS DPYD, TYMP, TP53 ADRB2 3297/4885NCF1 1444/4885PLD1 2887/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.